Nav: Home

Male birth control for the malaria parasite

January 31, 2019

Disrupting two genes involved in the preservation of RNA molecules inhibits the ability of the male form of the malaria parasite to mature and be transmitted from human blood into mosquitoes, interrupting a key stage in the parasite's life-cycle and cutting off an important step in the spread of the disease. Researchers at Penn State and the University of South Florida have identified a complex of proteins encoded by these genes that is crucial for the maturation of the male form--or gametocyte--of the Plasmodium parasite responsible for malaria; developing methods to target this complex with antimalarial drugs could lead to a new weapon in the fight against the disease. A paper describing the research appears January 31, 2019 in the journal PLOS Pathogens.

"Malaria continues to be an incredibly damaging global health problem, killing hundreds of thousands each year," said Scott Lindner, assistant professor of biochemistry and molecular biology at Penn State and the leader of the research team. "Malaria is transmitted when a mosquito takes a blood meal from an infected individual and ingests male and female Plasmodium gametocytes, the sexual stage of the parasite's life-cycle, which then mature in the mosquito. The gametocytes mate in the gut of the mosquito, and ultimately form sporozoites that can then be transmitted to other individuals. We were interested in identifying important molecular processes in the maturation of the sexual stage of the malaria parasite, which is required for transmission to mosquitoes, because targeting transmission events has been identified as a potentially effective way to fight the disease."

In humans, malaria parasites first take up residence in the liver, where they grow and multiply, eventually invading red-blood cells when symptoms appear. Most of these blood stage parasites continue to multiply asexually, killing red-blood cells and spreading to others. Some, however, produce male and female gametocytes. The gametocytes begin their maturation process in the blood, producing messenger-RNA (mRNA) molecules that code for proteins needed for their continued maturation, but the proteins are not actually made until the gametocytes are transmitted into a mosquito.

"The immature gametocytes in the blood must preserve and stabilize the mRNA that they will use to fully mature once they are in the gut of the mosquito," said Kevin J. Hart, a postdoctoral researcher at Penn State and first author of the paper. "We were interested in understanding the role of a complex of proteins known from other organisms to facilitate the degradation of mRNA by removing the protective poly(A)tail of mRNA."

The CAF1/CCR4/NOT complex of proteins contains two proteins, CAF1 and CCR4, that act as "deadenylases," enzymes that can remove poly(A) tails from mRNA reducing mRNA stability. When the researchers experimentally disrupted the genes for these proteins in malaria parasites, they expected that mRNA stability in gametocytes might increase; however, they saw the exact opposite.

"We were incredibly surprised to see that both CAF1 and CCR4 seemed to play a role in mRNA preservation in the gametocytes," said Hart. "When we disrupted the function of these proteins, by completely removing or creating non-functional versions of the CCR4 or CAF1 genes, mRNA levels decreased and the ability of the gametocytes to mature and infect mosquitoes was inhibited."

Male gametocytes form in synchronized waves in the blood and their maturation can be observed under a microscope. The researchers could therefore directly observe the disruption of the waves of formation and development, but they believe that the CAF1/CCR4/NOT complex is likely involved in maturation of both male and female gametocytes, which could make targeting this complex even more effective against malaria.

"If we can develop a safe way to target this complex with antimalarial drugs it could be an effective new tool that inhibits transmission of the disease," said Lindner. "It would act as a kind of birth control for the malaria parasite, limiting the ability of the parasite's sexual stage to reproduce in the mosquito, and as a consequence, reducing the spread of the disease."
In addition to Lindner and Hart, the research team includes Michael P. Walker, Allen M. Minns, and Mark F. Kennedy at Penn State; and Jenna Oberstaller, Ian Padykula, and John H. Adams at the University of South Florida.

Penn State

Related Malaria Articles:

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the Umeå University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.
Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.
New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.
Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.
Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.
Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.
Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.
The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.
Free malaria tests coupled with diagnosis-dependent vouchers for over-the-counter malaria treatment
Coupling free diagnostic tests for malaria with discounts on artemisinin combination therapy (ACT) when malaria is diagnosed can improve the rational use of ACTs and boost testing rates, according to a cluster-randomized trial published this week in PLOS Medicine by Wendy Prudhomme O'Meara of Duke University, USA, and colleagues.
More Malaria News and Malaria Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.